Navigation Links
ProMetic and Sartorius Stedim Biotech collaborate on technology transfer deals in Asia
Date:3/17/2008

contains forward-looking statements about ProMetic's objectives, strategies and businesses that involve risks and uncertainties. These statements are "forward-looking" because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate. Such risks and assumptions include, but are not limited to, ProMetic's ability to develop, manufacture, and successfully commercialize value-added pharmaceutical products, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of ProMetic to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. You will find a more detailed assessment of the risks that could cause actual events or results to materially differ from our current expectations on page 21 of ProMetic's Annual Information Form for the year ended December 31, 2006, under the heading "Risk Factors". As a result, we cannot guarantee that any forward-looking statement will materialize. We assume no obligation to update any forward-looking statement even if new information becomes available, as a result of future events or for any other reason, unless required by applicable securities laws and regulations.

About Sartorius Stedim Biotech

Sartorius Stedim Biotech (http://www.sartorius-stedim.com) is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab tech
'/>"/>

SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
2. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
3. ProMetic provides business update - Over $35 million worth of business secured in January
4. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
5. ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
6. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
9. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
10. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
11. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2008)...mpany,s Business Development ...ewswire-FirstCall/ -- Insulet Corporation,(Nasdaq:... its OmniPod(R),Insulin Management System, today a...ur III as Vice President of Business Development. ...usiness development strategy,including pursuing o...
(Date:9/3/2008)...d September 24 to 26 in Kansas City. , ...008 -— The U.S. Pharmacopeial (USP) Conventi...ll be held in Kansas City, Mo., September 24 to 26...he USP experts responsible for establishing intern...d over-the-counter medicines, food ingredients and...
(Date:9/3/2008)...SNewswire/ -- Mathematicians and,biologists from a...,Tennessee, Knoxville, to take part in a new insti...essing problems from animal disease to wildfire,co... awarded UT Knoxville $16,million to begin the Nat...nthesis, or NIMBioS. UT Knoxville won the award in...
(Date:9/3/2008)...-FirstCall/ -- United,Therapeutics Corporation (Na... Rx, Inc. announced today that the U.S. Food and D...he New Drug Application (NDA) for inhaled,treprost...tension. The NDA,will be subject to a standard rev...deadline of April 30, 2009., United Therapeutics ...
Breaking Biology Technology:Insulet Appoints Bill Arthur as Vice President of Business Development 2Insulet Appoints Bill Arthur as Vice President of Business Development 3Insulet Appoints Bill Arthur as Vice President of Business Development 4USP's 2008 Annual Scientific Meeting to Convene Scientific Experts from Around the World 2USP's 2008 Annual Scientific Meeting to Convene Scientific Experts from Around the World 3UT Knoxville Wins $16M Mathematics and Biology Center 2UT Knoxville Wins $16M Mathematics and Biology Center 3
...ad Part 1 . Winslow Sargeants combination of acad...im rare insight into the world of entrepreneurship...r remind him that to succeed at anything, tenacity...far removed from the place Sargeant knew as a chil...hur Garrity, Jr. ordered massive busing throughout...
...16 percent the past two years, Wisconsin,s bioscie...ically known for beer, brats, and milk, says Gale ...released today at the State Capitol in Madison. ,...ing that fast?" she asked. Davy is the executive d...al Research & Education , a non-profit group spons...
...Wisconsin company specializing in functional Magne..., announced today that the Food and Drug Administr...arket clearance of its trademarked MindState fDAD.... in February 2005 as an fMRI data acquisition devi...ance fDAD by providing a library of stimulation pa...
...ectorConnector , that connects businesses and non-...is up to 500 registered users, according to the tw...hael Best & Friedrich, LLP and the accounting fi...to connect organizations in need of specially-skil...idates. Recent surveys indicate that directors are...
Other Biology Technology:Winslow Sargeant: Stepping onto the train called Wisconsin - Part 2 2Winslow Sargeant: Stepping onto the train called Wisconsin - Part 2 3Winslow Sargeant: Stepping onto the train called Wisconsin - Part 2 4Bioscience beats beer 2
(Date:9/3/2008)...lm Vein Recognition Solution Named the Winner in t...ealthcare Category, SUNNYVALE, Calif., Sept. 3 /P..., Inc., a leading supplier of innovative computer ...nd biometric security solutions, announced,today t...on was named the,winner in the Best Security Solut...
(Date:9/3/2008)...NNE, Ill. (Sept. 3, 2008) Scientists at the U.S. ...ratory have won an $800,000 EUREKA award from the ...MAX, a precise molecular ruler for measuring dista...for the Multi-wavelength Anomalous Diffraction usi...ot only dramatically reduce the time necessary to ...
(Date:9/3/2008)...FAX, Va.Ten million Americans have peripheral arte...ghest risk populations include African-Americans (...seniors (12-20 percent develop PAD) and diabetics ...AD). Legs for Lifea community health and public in...ake its free, online self-assessment quiz. , The...
(Date:9/3/2008)...ation in the gene for one of the receptors for the... how human males bond with their partners, accordi...The researchers found that the "334" allele of a c...a studied in voles, seemed to have negative effect...Our findings are particularly interesting because ...
Breaking Biology News(10 mins):Fujitsu PalmSecure(TM) Wins Network Products Guide 2008 Reader Trust Award 2Fujitsu PalmSecure(TM) Wins Network Products Guide 2008 Reader Trust Award 3NIH awards Argonne $800,000 to develop tool to measure distances within proteins 2At risk for peripheral arterial disease? Simple quiz provides key so you can circulate better 2At risk for peripheral arterial disease? Simple quiz provides key so you can circulate better 3Gene associated with pair-bonding in animals has similar effects in human males 2Gene associated with pair-bonding in animals has similar effects in human males 3Celldex Therapeutics Receives Fast Track Designation for CDX 110 a Novel EGFRvIII Vaccine for Glioblastoma 1143 1Celldex Therapeutics Receives Fast Track Designation for CDX 110 a Novel EGFRvIII Vaccine for Glioblastoma 1143 2Celldex Therapeutics Receives Fast Track Designation for CDX 110 a Novel EGFRvIII Vaccine for Glioblastoma 1143 3Celldex Therapeutics Receives Fast Track Designation for CDX 110 a Novel EGFRvIII Vaccine for Glioblastoma 1143 4Celldex Therapeutics Receives Fast Track Designation for CDX 110 a Novel EGFRvIII Vaccine for Glioblastoma 1143 5Difficult to Treat Erectile Dysfunction Patients 2474 1Difficult to Treat Erectile Dysfunction Patients 2474 2Difficult to Treat Erectile Dysfunction Patients 2474 3A special issue of the International Journal of Plant Sciences 1788 1A special issue of the International Journal of Plant Sciences 1788 2A special issue of the International Journal of Plant Sciences 1788 3UCLA scientists restore walking after spinal cord injury 9123 1UCLA scientists restore walking after spinal cord injury 9123 2UCLA scientists restore walking after spinal cord injury 9123 3
... family,s ancestors roamed 60,000 years ago? ,Now ...ost ambitious project tracing the genetic and migr...general public from all over the world can supply ...ts at The University of Arizona in Tucson will do ...art of a larger undertaking to unravel the origins...
...ter it burst onto the scene, HIV/AIDS has claimed ...vastate societies around the world, particularly i...te 1980s and early 1990s, after years of effort AI...drugs that proved to be highly effective against A...HIV protease, these protease inhibitors brought gr...
...ffensive strategies can become weaknesses, if the ...its weapons. , By manipulating what is perhaps th...ox viruses like smallpox, Arizona State University...tram Jacobs believes that he can turn the biochemi...s ?and protect the public against catastrophic bio...
...l University Health Centre (MUHC), in Montreal, ha...w study, published in the on-line edition of the j...earchers document a reduction in the growth of bot...the gene. , The new target gene is called methylen... were able to inhibit the function of the gene by ...
Other Biology News:The biggest family tree ever 2The biggest family tree ever 3Supercomputers to focus brains on AIDS dilemma 2Supercomputers to focus brains on AIDS dilemma 3Supercomputers to focus brains on AIDS dilemma 4Secret of smallpox's success may lead to bioterror cure 2Secret of smallpox's success may lead to bioterror cure 3Secret of smallpox's success may lead to bioterror cure 4Secret of smallpox's success may lead to bioterror cure 5
... HistoMark Biotin Streptavidin-HRP Systems provide...ntracellular antigens in frozen or paraffin-embedd...e systems also facilitate double or triple labelei...ltaneously with primary antibodies of different an...
Polystyrene covers can be used with all 96-well plates Ridged covers for stacking of covered plates Non-ridged covers for use with automated systems Polypropylene covers, ridged and non-ridged,
SYBR Green Nucleic Acid Dye
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,670-7) or contact custom
Biology Products: